Self-administrated vaginal 2% lidocaine in-situ gel for pain relief during copper intrauterine device insertion in women with previous caesarean delivery only: a randomised, double-blind placebo-controlled trial
Type
Retraction
Notice date
8/17/2023 0:00
Journal
European Journal of Contraception & Reproductive Health Care